Histoplasmosis presenting as cellulitis 18 years after renal transplantation

References

• Sweny P, Burroughs AK. Infections in solid organ transplantation. Curr Opin Infect Dis 1994; 7: 436–443
   Google Scholar
• Miller LW, Naftel DC, Bourge RC, et al. and the Cardiac Transplant Research Database Group. Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1994; 13: 381–392
   PubMedGoogle Scholar
• Cano MVC, Hajjen RA. The epidemiology of histoplasmosis: a review. Semin Respir Infect 2001; 16: 109–118
   PubMedGoogle Scholar
• Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med 1982; 96: 159–163
   PubMed Web of Science ®Google Scholar
• Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis 1992; 14: 232–234
   PubMed Web of Science ®Google Scholar
• Kauffman CA, Israel KE, Smith JW, et al. Histoplasmosis in immunosuppressed patients. Am J Med 1978; 64: 923–932
   PubMed Web of Science ®Google Scholar
• Goodwin RA, Jr, Shapiro JL, Thurman GH, et al. Disseminated histoplasmosis: clinic and pathologic correlations. Medicine 1980; 59: 1–33
   PubMed Web of Science ®Google Scholar
• Wheat L. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Topics Med Mycol 1996; 7: 7–18
   PubMedGoogle Scholar
• Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximabe and etanercept. Arthritis Rheum 2002; 46: 2565–2570
   PubMed Web of Science ®Google Scholar
• Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996; 10: 160–165
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch Intern Med 1983; 143: 703–707
   PubMed Web of Science ®Google Scholar
• Vail GM, Young RS, Wheat LJ, et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4: 148–151
   PubMedGoogle Scholar
• Delfino VDA, Matni AM, Gordan PA, Mocelin AJ. Micoses profundas em transplantados renais: indicação de alerta clinico. J Bras Nefrol 1994; 16: 143–148
   Google Scholar
• Uip DE, Amato Neto V, Strabelli MV, et al. Infecções fúngicas em 100 pacientes submetidos a transplante cardíaco. Arq Bras Cardiol 1996; 66: 65–67
   Google Scholar
• Bacal F, Andrade ACM, Migueletto, et al. Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas disease. Arq Bras Cardiol 2001; 76: 406–408
   Google Scholar
• Marques SA, Robles M, Tortorano AM, et al. Mycosis associated with AIDS in the third world. Med Mycol 2000; 38(Suppl. 1)269–279
   Google Scholar
• Wheat LJ, Connoly-Striengfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990; 69: 361–374
   PubMed Web of Science ®Google Scholar
• Tobón AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73: 576–582
   PubMed Web of Science ®Google Scholar
• Chang MR, Taira CL, Paniago AMM, et al. Study of 30 cases of histoplasmosis observed in Mato Grosso do Sul state, Brazil. Rev Inst Med Trop S Paulo 2007; 49: 37–39
   Google Scholar
• Motta ACF, Galo R, Lourenço AG, et al. Unusual orofacial manifestation of histoplasmosis in renal transplanted patient. Mycopathologia 2006; 161: 161–165
   Google Scholar
• McGuinn ML, Lawrence LP, Segreti J. Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. J. Transplant Proc 2005; 37: 4313–4314
   Google Scholar
• Pasqualoto AC, Bittar AEN, Quadros M, Severo LC. Cryptococcal cellulitis in a renal transplant patient. Nephrol Dial Transplant 2005; 20: 2007–2008
   Google Scholar
• Van Grieeken SAH, Dupont LJ, Van Raemdonck DEM, Van Bleyenbergh P, Verleden GM. Primary cryptococcal cellulitis in a lung transplant patient. J Heart Lung Transplant 2007; 26: 285–289
   Google Scholar
• Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guideline for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 807–825
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH 56592 and the echinocandins MK-0991(L – 743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956
   PubMed Web of Science ®Google Scholar
• Connoly P, Wheat LJ, Schnizlein-Bick C, et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000; 44: 2604–2608
   Google Scholar
• Restrepo A, Tobón A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54: 319–327
   PubMed Web of Science ®Google Scholar